wow effect !

Well here are my notes below without comment.

My feel was the boss was under the pump but hitting every milestone. kraws was trying to squeeze some growth is sales predictions out of him but he was sticking to his current projections of 1bn units by 2016. as they said it represents only 14& of mkt use by then and sanofi alone will be at 40%..... i dont think they need that kind of growth in their face at the moment with all the work they are doing to get the factory, the industrialisation program and everything else bolted together. All i can say is they are doing an awesome job!!!!!!!!!!!


UNS

Poised to capatalise on the market
Accelerating tasks

We will Help Pharmas protect Bns in sales, help panients and workers with better health and safety outcomes.

Sanofis alliance validates our product
We continue to build products, partners and people
Continue to derisk the production

We now have 175 staff

Mortgage to soon be negotiated returning $5M to cash balance and triggers govenment money to flow.

Add talent to the team like Wold and Marc, they will use their immense experience and talent to negotiate with the big pharmas our supply agreements.

Production facility on sched
8 class 8 clean rooms
3 class 7 clean rooms
plus other labs and research areas and office for 250 staff

1ml Syringe 30-40M units PA
insuline approved but is in units as a measurement
TB not yet approved but in CC's and for hospitals
taking time to evaluate partners
Substantial opportunities, no agrements till they sign up for min numbers.

Unifill.
$40M from sanofi for 5yr exclusive rights.
Millions of tasks to validate the program
A giant Gig saw
Confidence when it turns on
Hit 9 of the 11 milestones right on!!!!

When evaluated our product against current competitors and health care workers gave a 100% preference to our product.

Our time line
400M units 2014
1bn units 2016
this represents a small proportion of the 83 blockbuster drugs in the pipeline. These drugs represent 26bn in combined sales out to 2015.
Our product can protect them from Generic competitors
Extend the life cycle
retain and protect MKT share

Questions from callers

We have a 5 person sales team and 1 director
We sell to destributor and they market the product not us.
talking to 15-20 Pahrmas
we are burning $2-3M a month in cash

Review of major steps to production.
Move in in DEC
Be in full production end 1st QTR
Wash equip moving to colorado to link up with Mykron line

Share price fallen?
No material events
Key milestones hit
Therapudic list agreed which opens up opportunities with others
FDA 1ml approval
Expand board
Very confident

Kraws Questions?
Top 10 pharmas moving to next level of negotiations
400M in 2014
1bn in 2016 represents only 14% of prefill MKT
Sanofi alone represents 40% of market

The WOW effect for pharmas and health care workers.